Good MorningEquity markets continue to consolidate within a tight range while market participants wait on the next FOMC decision. The S&P 500 gained more than half a percent on Thursday but traded within the same range it's been in all week. Given the outlook for interest rates, the market remains below the critical 4,300 level and may not rise above it. The FOMC is unlikely to indicate a reduction in interest rates is coming soon and may give reason to believe another interest rate increase is the more likely scenario.
Next week will be a turning point for the market. Along with the FOMC meeting is another look at the CPI index, retail sales data, and a host of reports on manufacturing conditions across the US. Even if it means higher rates for longer, good data could lift the market and take it above 4,300. In that scenario, the S&P 500 could drift up to retest the all-time high by mid-summer. Featured: Watch This Robotics Demo Before July 23rd (Ad) 
|
Markets | | The S&P 500 is now in what Wall Street refers to as a bull market, meaning the index has risen 20% or more from its most recent low. Here are some answers to questions about bull and bear markets:WHY IT IS CALLED A BULL MARKET? Wall Street’s nickname for a surging stock market is a bull market b... Read the Full Story |
|
|
Markets | |
There have been plenty of headlines in recent weeks regarding the influence a few tech titans are having on the broader market rally that's underway, with some voices suggesting the S&P 500 would actually be down for the year if it were not for their outperformance.
But that's not to sa... Read the Full Story |
|
Stocks | | Stocks inched higher Friday to close out a listless week for Wall Street, as investors wait for next week’s slate of potentially market-moving updates. The S&P 500 rose 4.93, or 0.1%, to 4,298.86 to cap its fourth straight winning week. The Dow Jones Industrial Average added 43.17, or 0.1%, to 3... Read the Full Story |
|
|
Markets | | North Korea has tolerated the widespread use of more stable foreign currencies like U.S. dollars and the Chinese yuan since a bungled revaluation of the won in 2009 triggered runway inflation and public unrest Read the Full Story |
|
Markets | |
As the second quarter 2023 earnings season comes to a close, many analysts and investors are on a tight lookout for new developments and improvements within various sectors. With the real estate market slowing down amid the United State's FED interest rate hike paths as an attempt to combat rampan... Read the Full Story |
|
From Our Partners2025 is off to a turbulent start—markets are swinging wildly, inflation pressures remain high, and recession fears are creeping back into headlines.
But even in uncertain times, innovation doesn’t slow down.
In fact, artificial intelligence (AI) is accelerating faster than ever—creating new profit opportunities while the broader market struggles.
Our latest research reveals two AI stocks trading under $15 that could thrive even as volatility grows. These under-the-radar companies are positioned to ride the next wave of AI-driven demand—and they’re still flying below most investors’ radar. | | 👉[Click here to access your FREE AI stocks report now.] |
|
Markets | | Turkish President Recep Tayyip Erdogan won reelection last month despite a battered economy and a cost-of-living crisis that experts say are exacerbated by his unconventional economic policies. The longtime leader appointed an internationally respected former banker as finance and treasury minister ... Read the Full Story |
|
Markets | | Turkish President Recep Tayyip Erdogan appointed a former U.S.-based bank executive to head the central bank Friday, sending the strongest signal yet that the newly reelected leader might pivot from his unusual economic policies that many blame for worsening a cost-of-living crisis.Hafize Gaye Erkan... Read the Full Story |
|
Markets | |
Stitch Fix (NASDAQ: SFIX) popped following its Q3 results, but the rally may already be over. The news wasn’t great; better than expected is the best that can be said, and the core driver of the surge, short interest, isn’t going away. Near-term headwinds persist, and the path to profi... Read the Full Story |
|
Markets | |
May 18th is important for REV Group (NYSE: REVG) shareholders. That is the day interim CEO and CFO Mark Skonieczny became the official CEO and president. It is also the day the rebound began, the day the market confirmed a bottom that was first reached in 2022. Mr. Skonieczny has been with the com... Read the Full Story |
|
Markets | |
As one of the backbones of the American economy as consumers know it today, the real estate market is the center-hub point for a variety of other industries that depend on the underlying activity and volumes of the main. As inflation rates in the United States ran their path to multi-year highs, t... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. | View Today's Stock Pick |
|